News

Technology News

BiO2 Medical Bags Venture Capital Funding

Friday, January 8, 2016 5:01:00 AM PDT | VentureDeal
   San Antonio, Texas  --  Medical device technology company BiO2 Medical has secured $14 million in venture capital equity and debt investment.

BiO2 has developed what it calls the Angel Catheter which was designed to protect critically ill patients from acute pulmonary embolism.

The unique design provides a retrievable inferior Vena Cava filter which is attached to a triple lumen central venous catheter.

Oxford Finance provided $5 million of the amount in the form of venture debt.

Unnamed investors provided $9 million as the fourth equity funding round.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1